In particular, the balance of inflammatory Type I cytokines, such as interferon gamma (IFNG) and tumour necrosis factor (TNF), with Type II cytokines, e.g., interleukin 4 (IL4) and IL10, is thought to determine the lethality of cerebral malaria [18, 19]. The gene discussed is IFNG; the disease is cerebral malaria.